This inventor holds 3 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: National Institute of Health and Medical Research, Universite Dé Lorraine, Université Paris Descartes. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,853 
3 out of 93 
3 out of 132 
Years Active: 2015-2019
Title: Faiez Zannad: Innovator in Cardiovascular Treatment
Introduction
Faiez Zannad is a prominent inventor based in Vandoeuvre-les-Nancy, France. He has made significant contributions to the field of cardiovascular medicine, particularly through his innovative patents. With a total of three patents to his name, Zannad is recognized for his work in developing methods for treating cardiovascular fibrosis.
Latest Patents
Zannad's latest patents focus on methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis. One of his notable inventions involves an inhibitor of Neutrophil Gelatinase-Associated Lipocalin (NGAL) activity or expression. This invention is aimed at treating or preventing cardiovascular fibrosis in subjects in need of such intervention. His work in this area has the potential to significantly impact the treatment of cardiovascular diseases.
Career Highlights
Throughout his career, Faiez Zannad has been associated with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Lorraine. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Zannad has collaborated with notable colleagues, including Frederic Jaisser and Patrick Rossignol. These partnerships have further enriched his research and innovation in the field of cardiovascular health.
Conclusion
Faiez Zannad is a distinguished inventor whose work in cardiovascular treatment has garnered attention and respect in the medical community. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile